Let’s talk about something that sounds simple… but isn’t.
You hear about lower drug prices.
You hear about something like “TrumpRx.”
You think:
“Well great. I’ll just order my meds from trumprx.gov and skip the pharmacy.”
That sounds efficient.
It’s also where things can get messy.
So let’s break this down the way normal humans talk about it.
Starting in 2026, the most you can pay out-of-pocket for covered prescription drugs under Medicare Part D is $2,100 for the entire year.
That’s your ceiling.
Once you hit $2,100 in covered drug costs:
You’re done paying for covered meds for the rest of that calendar year.
That matters more than almost any headline.
Short answer:
Usually, no.
Long answer:
It depends — but most Medicare beneficiaries are better off staying inside their drug plan.
Let’s walk through both sides.
There are a few scenarios where someone might be tempted:
If a medication isn’t on your formulary, you may be paying full price anyway.
In that case, comparing outside pricing could make sense.
Sometimes a $12 generic is cheaper cash than running it through insurance.
If:
Then comparing options isn’t crazy.
If someone takes:
They might shop around occasionally without major downside.
But now let’s talk about why this often backfires.
Here’s the big issue.
When you buy medications outside of:
Those purchases typically:
So if you later have a year where:
You’ve lost the tracking benefit.
And at that point, the cap becomes very valuable.
Here’s the reality most people miss:
The $2,100 cap in 2026 is catastrophic protection.
It protects you from:
If you step outside the system chasing a slightly cheaper monthly cost, you may lose that long-term protection.
That’s like canceling your homeowner’s insurance because you haven’t had a fire lately.
It feels smart… until it isn’t.
Even if drug pricing reforms expand under new initiatives, those changes are typically implemented through:
Not by replacing your Medicare card with a different website.
Instead of asking:
“Should I ditch my Medicare drug plan?”
The better question is:
“Should we compare my total annual cost inside my Medicare plan versus outside options?”
That’s a math problem. Not a political one.
And most of the time — especially for Medicare Advantage clients — staying within your plan structure wins because:
TrumpRx discussions are about lowering drug prices.
That’s good.
But Medicare beneficiaries already have a powerful protection built into the system for 2026:
A $2,100 annual out-of-pocket maximum under Part D.
Before bypassing your coverage:
✔ Compare total annual cost
✔ Consider worst-case scenarios
✔ Understand what counts toward the cap
✔ Run the numbers — don’t guess
Because the goal isn’t to chase headlines.
It’s to make sure you’re never surprised at the pharmacy counter… especially in the year you need the protection most.